Seres Therapeutics, Inc. · NASDAQ:MCRB
Seres Therapeutics, Inc. shareholders
As of Sep 30, 2026, 38 institutions reported holding Seres Therapeutics, Inc., 23.0% of its shares. Largest: Flagship Pioneering, LLC, Vanguard and Marshall Wace, LLP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Seres Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Flagship Pioneering, LLC | 1.16M | 11.3% | no change | Nov 16, 2026 |
| Vanguard | 337K | 3.3% | −1,371 | Nov 13, 2026 |
| Marshall Wace, LLP | 139K | 1.4% | −32,967 | Nov 13, 2026 |
| Jacobs Levy Equity Management, Inc | 134K | 1.3% | new | Nov 16, 2026 |
| Vontobel Holding Ltd. | 115K | 1.1% | −8,409 | Oct 16, 2026 |
| BlackRock | 110K | 1.1% | −1,173 | Nov 13, 2026 |
| Geode Capital | 78,898 | 0.77% | −1,076 | Nov 6, 2026 |
| Susquehanna | 62,692 | 0.61% | +4,364 | Nov 16, 2026 |
| State Street | 33,901 | 0.33% | no change | Nov 12, 2026 |
| Lion Point Capital, LP | 31,570 | 0.31% | no change | Nov 16, 2026 |